CTXR
Citius Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.60
+2.06%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+3.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 23, 2025 | Mazur Leonard L · director, officer: Chief Executive Officer | A-Award | 125,490 | $29 |
| Sep 23, 2025 | Mazur Leonard L · director, officer: Chief Executive Officer | A-Award | 89,388 | $19 |
| Aug 12, 2025 | HOLUBIAK MYRON Z · director, officer: Vice Chairman | A-Award | 31,373 | $29 |
| Aug 12, 2025 | HOLUBIAK MYRON Z · director, officer: Vice Chairman | A-Award | 22,344 | $19 |
| Nov 12, 2024 | Webb Carol · director | A-Award | 125,000 | $0.38 |
| Nov 12, 2024 | Smith Robert Joseph · director | A-Award | 125,000 | $0.38 |
| Nov 12, 2024 | Bartushak Jaime · officer: Chief Financial Officer | A-Award | 350,000 | $0.38 |
| Nov 12, 2024 | Mazur Leonard L · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 600,000 | $0.38 |
| Nov 12, 2024 | Czuczman Myron · officer: Chief Medical Officer | A-Award | 300,000 | $0.38 |
| Nov 12, 2024 | Dutia Suren G · director | A-Award | 125,000 | $0.38 |
| Nov 12, 2024 | MCGRATH DENNIS M · director | A-Award | 125,000 | $0.38 |
| Nov 12, 2024 | HOLUBIAK MYRON Z · director, officer: Vice Chairman | A-Award | 350,000 | $0.38 |
| Nov 12, 2024 | HOLUBIAK MYRON Z · director, officer: Vice Chairman | A-Award | 75,000 | $0.38 |
| Nov 12, 2024 | Holuka Eugene Myron · director | A-Award | 125,000 | $0.38 |
| Sep 27, 2024 | HOLUBIAK MYRON Z · director, officer: Vice Chairman | A-Award | 784,314 | $1.15 |
| Sep 27, 2024 | HOLUBIAK MYRON Z · director, officer: Vice Chairman | A-Award | 558,597 | $0.77 |
| Sep 27, 2024 | Mazur Leonard L · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 3,137,255 | $1.15 |
| Sep 27, 2024 | Mazur Leonard L · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 2,234,700 | $0.77 |
| Aug 30, 2024 | Holuka Eugene Myron · director | M-Exempt | 2,415 | $0.01 |
| Aug 30, 2024 | Holuka Eugene Myron · director | F-InKind | 48 | $0.75 |
| Aug 30, 2024 | Webb Carol · director | M-Exempt | 12,071 | $0.01 |
| Aug 30, 2024 | Webb Carol · director | F-InKind | 236 | $0.77 |
| Apr 5, 2024 | Mazur Leonard L · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 1,165,048 | $1.42 |
| Apr 5, 2024 | HOLUBIAK MYRON Z · director, officer: Vice Chairman | A-Award | 129,450 | $1.42 |
| Mar 18, 2024 | Smith Robert Joseph · director | A-Award | 75,000 | $0.69 |
| Oct 12, 2023 | Webb Carol · director | A-Award | 75,000 | $0.70 |
| Oct 12, 2023 | Czuczman Myron · officer: Chief Medical Officer | A-Award | 300,000 | $0.70 |
| Oct 12, 2023 | HOLUBIAK MYRON Z · director, officer: Vice Chairman | A-Award | 400,000 | $0.70 |
| Oct 12, 2023 | Holuka Eugene Myron · director | A-Award | 75,000 | $0.70 |
| Oct 12, 2023 | MCGRATH DENNIS M · director | A-Award | 75,000 | $0.70 |
Institutional positioning
13F filings over the trailing two quarters
New 21Increased 15Reduced 17Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 246,158 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 215,537 | Aug 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 197,364 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 167,738 | May 15, 2026 |
| Miller Financial Services LLC | Increased | 130,000 | Jul 29, 2026 |
| CITADEL ADVISORS LLC | Increased | 124,910 | Sep 2, 2026 |
| JANE STREET GROUP, LLC | Increased | 122,837 | Aug 14, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 77,755 | May 8, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Unchanged | 77,755 | Aug 13, 2026 |
| BLACKROCK, INC. | Unchanged | 69,851 | May 13, 2026 |
| BlackRock, Inc. | Reduced | 69,850 | Aug 7, 2026 |
| NORTHERN TRUST CORP | Increased | 62,742 | Aug 13, 2026 |
| HRT FINANCIAL LP | New Position | 60,332 | May 14, 2026 |
| XTX Topco Ltd | Increased | 59,199 | Aug 14, 2026 |
| Asset Advisory Group, Inc. | Unchanged | 59,011 | Jul 9, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 23, 2025